Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.68B | $1.79B | $1.83B | $1.86B | $1.69B | $1.73B | $1.92B | $2.30B | $2.31B | $2.53B |
| Revenue growth | — | 6.9% | 2.2% | 1.4% | -9.2% | 2.5% | 10.8% | 19.8% | 0.6% | 9.6% |
| Gross profit | $668M | $695M | $690M | $688M | $605M | $620M | $610M | $763M | $771M | $867M |
| Gross margin | 39.8% | 38.7% | 37.6% | 37.0% | 35.9% | 35.8% | 31.8% | 33.2% | 33.3% | 34.2% |
| Operating income | $512M | $523M | $508M | $489M | $400M | $410M | $370M | $496M | $460M | $474M |
| Operating margin | 30.5% | 29.2% | 27.7% | 26.3% | 23.7% | 23.7% | 19.3% | 21.6% | 19.9% | 18.7% |
| Net income | $348M | $407M | $438M | $425M | $348M | $361M | $319M | $428M | $404M | $385M |
| Net margin | 20.7% | 22.7% | 23.9% | 22.8% | 20.6% | 20.8% | 16.6% | 18.6% | 17.5% | 15.2% |
| EPS (diluted) | $1.19 | $1.41 | $1.62 | $1.66 | $1.41 | $1.50 | $1.36 | $1.84 | $1.76 | $1.74 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $477M | $501M | $552M | $506M | $464M | $362M | $338M | $537M | $498M | $587M |
| Capital expenditures | $121M | $104M | $86.0M | $84.6M | $51.7M | $68.8M | $146M | $184M | $145M | $129M |
| Free cash flow | $356M | $397M | $466M | $421M | $413M | $293M | $192M | $354M | $354M | $458M |
| Share buybacks | $163M | $231M | $592M | $331M | $288M | $325M | $113M | $147M | $206M | $315M |
| Dividends paid | $101M | $109M | $117M | $116M | $117M | $115M | $113M | $112M | $110M | $107M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $546M | $570M | $217M | $296M | $423M | $262M | $215M | $226M | $233M | $146M |
| Total assets | $2.31B | $2.35B | $2.09B | $2.17B | $2.20B | $2.13B | $2.33B | $2.61B | $2.76B | $2.93B |
| Total liabilities | $399M | $303M | $224M | $231M | $234M | $193M | $261M | $299M | $289M | $438M |
| Long-term debt | $178M | $0.00 | — | — | — | — | — | — | — | — |
| Shareholders' equity | $1.91B | $2.05B | $1.86B | $1.94B | $1.96B | $1.94B | $2.07B | $2.31B | $2.47B | $2.49B |
| Retained earnings | $1.21B | $1.30B | $1.10B | $1.12B | $1.09B | $1.04B | $1.15B | $1.34B | $1.45B | $1.47B |
| Shares (wtd avg diluted) | 291M | 288M | 270M | 253M | 244M | 237M | 231M | 230M | 226M | 218M |
Every figure is extracted from GENTEX CORP’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.